LogicBio Therapeutics Inc
NASDAQ:LOGC
Income Statement
Earnings Waterfall
LogicBio Therapeutics Inc
Revenue
|
10.8m
USD
|
Operating Expenses
|
-36.6m
USD
|
Operating Income
|
-25.9m
USD
|
Other Expenses
|
-654k
USD
|
Net Income
|
-26.5m
USD
|
Income Statement
LogicBio Therapeutics Inc
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
2
+95%
|
3
+47%
|
3
+18%
|
3
-16%
|
3
-6%
|
4
+44%
|
5
+38%
|
8
+44%
|
10
+31%
|
11
+6%
|
|
Operating Income | |||||||||||||||||||
Operating Expenses |
(10)
|
(14)
|
(18)
|
(24)
|
(31)
|
(37)
|
(41)
|
(43)
|
(42)
|
(39)
|
(35)
|
(35)
|
(37)
|
(41)
|
(44)
|
(43)
|
(40)
|
(37)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(7)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(12)
|
(12)
|
(13)
|
(14)
|
(15)
|
(16)
|
(16)
|
(15)
|
(14)
|
|
Research & Development |
(6)
|
(8)
|
(11)
|
(15)
|
(21)
|
(27)
|
(31)
|
(32)
|
(30)
|
(27)
|
(23)
|
(22)
|
(23)
|
(26)
|
(28)
|
(27)
|
(25)
|
(22)
|
|
Operating Income |
(10)
N/A
|
(14)
-35%
|
(18)
-32%
|
(24)
-32%
|
(31)
-29%
|
(37)
-21%
|
(41)
-11%
|
(42)
-3%
|
(40)
+6%
|
(37)
+8%
|
(32)
+14%
|
(32)
-2%
|
(34)
-7%
|
(37)
-6%
|
(39)
-6%
|
(35)
+9%
|
(30)
+15%
|
(26)
+14%
|
|
Pre-Tax Income | |||||||||||||||||||
Interest Income Expense |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
|
Pre-Tax Income |
(10)
N/A
|
(14)
-36%
|
(18)
-30%
|
(23)
-31%
|
(29)
-28%
|
(36)
-21%
|
(40)
-13%
|
(42)
-4%
|
(40)
+4%
|
(37)
+7%
|
(32)
+13%
|
(33)
-3%
|
(36)
-7%
|
(38)
-6%
|
(40)
-6%
|
(36)
+9%
|
(31)
+15%
|
(27)
+14%
|
|
Net Income | |||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(10)
|
(14)
|
(18)
|
(23)
|
(29)
|
(36)
|
(40)
|
(42)
|
(40)
|
(37)
|
(33)
|
(33)
|
(36)
|
(38)
|
(40)
|
(36)
|
(31)
|
(27)
|
|
Net Income (Common) |
(10)
N/A
|
(14)
-37%
|
(18)
-30%
|
(23)
-31%
|
(29)
-28%
|
(36)
-21%
|
(40)
-12%
|
(42)
-4%
|
(40)
+4%
|
(37)
+7%
|
(33)
+12%
|
(33)
-3%
|
(36)
-7%
|
(38)
-6%
|
(40)
-6%
|
(36)
+9%
|
(31)
+15%
|
(27)
+14%
|
|
EPS (Diluted) |
-0.25
N/A
|
-0.66
-164%
|
-3.04
-361%
|
-1.03
+66%
|
-1.31
-27%
|
-1.58
-21%
|
-1.75
-11%
|
-1.81
-3%
|
-1.72
+5%
|
-1.58
+8%
|
-1.04
+34%
|
-1.05
-1%
|
-1.11
-6%
|
-1.17
-5%
|
-1.21
-3%
|
-1.1
+9%
|
-0.94
+15%
|
-0.81
+14%
|